Lakewood-Amedex Biotherapeutics Inc. — All Filings
6 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-1/A | REGISTRATION STATEMENT | 0001213900-26-026195 | Mar 11, 2026 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-26-015814 | Feb 13, 2026 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-26-012492 | Feb 5, 2026 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-26-003037 | Jan 9, 2026 | — |
| DRS/A | — | 0001213900-25-100021 | Oct 17, 2025 | — |
| DRS | — | 0001213900-25-070092 | Jul 31, 2025 | — |